Jim Bochnowski founded Delphi Ventures in 1988. His focus is on medical devices and biotechnology. Jim began investing in medical companies in 1981 after co-founding Technology VENTURE Investors, a private venture capital partnership. Since 1984, he has focused exclusively on healthcare investments. From 1976 to 1980, Jim was with Shugart Associates, a venture-backed disk drive company. As President and CEO, he led Shugart to increasing profitability, with annual revenues growing from $13 million to $200 million. Shugart was acquired by Xerox in 1979. From 1972 to 1976, Jim was a general partner with Donaldson Lufkin & Jenrette’s (DLJ) venture capital arm, the Sprout Capital Group. Prior to that, he served as a securities analyst with DLJ. Trained as an aerospace engineer at MIT, Jim served as an Army officer and a missile systems engineer with the U.S. Army Missile Intelligence Directorate, serves on the Board of Overseers of the Hoover Institution at Stanford University and was a member of the Harvard School of Public Health’s Health Policy and Management Executive Council. Jim was a director of the Western Association of Venture Capital. Jim received his MBA with Distinction from Harvard University Graduate School of Business and his BS from MIT.